Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort.
Daniel Martinez-RevueltaJuan Irure-VenturaMarcos López-HoyosJosé Manuel OlmosEmilio ParienteMarta Martín-MillánDaniel NanAlejandra Comins-BooVíctor Manuel Martínez-TaboadaJosé Luis HernándezPublished in: Clinical chemistry and laboratory medicine (2023)
ANA detection by IIF may be better when the pre-test probability is high, whereas SPA techniques are more useful in populations with an overall low pre-test probability for systemic AID.